| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824372 | Clinical Therapeutics | 2016 | 12 Pages |
Abstract
PARPi hold great promise in the treatment of solid tumors, both as monotherapy and in combination with other cancer therapeutics. Multiple PARPi clinical trials are currently underway. Further understanding of aberrant DNA repair mechanisms in the germline and in the tumor genome will allow clinicians and researchers to apply PARPi most strategically in the era of personalized medicine.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Karen MD, Erin MD,